Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira A Jacobs

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The American Surgeon|May 29, 2003
Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumorsIra A Jacobs, C K Chang, George Salti
Journal of Geriatric Oncology|February 10, 2016
Biosimilars and cancer treatment of older patientsStuart M Lichtman, Thomas Reske, Ira A Jacobs
Mabs|May 12, 2015
Regulatory considerations in oncologic biosimilar drug developmentJudith C Macdonald, Helen Hartman, Ira A Jacobs
International Journal of Gastrointestinal Cancer|January 13, 2004
Interdisciplinary approach to abdominal Burkitt's lymphomaIra A Jacobs, C K Chang, Vida Vizgirda
Targeted Oncology|August 13, 2017
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of BiosimilarsLee S Rosen, Ira A Jacobs, Ronald L Burkes
Journal of the American Academy of Dermatology|September 27, 2003
Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsyIra A Jacobs, C K Chang, George I Salti
American Journal of Industrial Medicine|March 29, 2002
Poisoning as a result of barium styphnate explosionIra A Jacobs, Joseph Taddeo, Kathleen Kelly, et al.
The American Surgeon|December 14, 2004
Coexistence of pregnancy and cancerIra A Jacobs, C K Chang, George I Salti
The American Surgeon|February 18, 2004
Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanomaIra A Jacobs, C K Chang, George I Salti
Drug Discovery Today|January 10, 2015
Considerations in the early development of biosimilar productsEdward C Li, Richat Abbas, Ira A Jacobs, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The American Surgeon|May 29, 2003
Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumorsIra A Jacobs, C K Chang, George Salti
Journal of Geriatric Oncology|February 10, 2016
Biosimilars and cancer treatment of older patientsStuart M Lichtman, Thomas Reske, Ira A Jacobs
Mabs|May 12, 2015
Regulatory considerations in oncologic biosimilar drug developmentJudith C Macdonald, Helen Hartman, Ira A Jacobs
International Journal of Gastrointestinal Cancer|January 13, 2004
Interdisciplinary approach to abdominal Burkitt's lymphomaIra A Jacobs, C K Chang, Vida Vizgirda
Targeted Oncology|August 13, 2017
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of BiosimilarsLee S Rosen, Ira A Jacobs, Ronald L Burkes
Journal of the American Academy of Dermatology|September 27, 2003
Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsyIra A Jacobs, C K Chang, George I Salti
American Journal of Industrial Medicine|March 29, 2002
Poisoning as a result of barium styphnate explosionIra A Jacobs, Joseph Taddeo, Kathleen Kelly, et al.
The American Surgeon|December 14, 2004
Coexistence of pregnancy and cancerIra A Jacobs, C K Chang, George I Salti
The American Surgeon|February 18, 2004
Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanomaIra A Jacobs, C K Chang, George I Salti
Drug Discovery Today|January 10, 2015
Considerations in the early development of biosimilar productsEdward C Li, Richat Abbas, Ira A Jacobs, et al.
Pageof 4